Financials data is unavailable for this security.
View more
Year on year Cencora Inc had net income fall -13.53% from 1.75bn to 1.51bn despite a 12.12% increase in revenues from 262.17bn to 293.96bn.
| Gross margin | 3.35% |
|---|---|
| Net profit margin | 0.52% |
| Operating margin | 0.74% |
| Return on assets | 2.34% |
|---|---|
| Return on equity | 230.62% |
| Return on investment | 11.51% |
More ▼
Cash flow in USDView more
In 2024, Cencora Inc increased its cash reserves by 19.80%, or 544.99m. The company earned 3.48bn from its operations for a Cash Flow Margin of 1.19%. In addition the company used 618.10m on investing activities and also paid 2.33bn in financing cash flows.
| Cash flow per share | 13.16 |
|---|---|
| Price/Cash flow per share | 18.32 |
| Book value per share | 3.99 |
|---|---|
| Tangible book value per share | -63.60 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.8792 |
|---|---|
| Quick ratio | 0.5291 |
| Total debt/total equity | 5.58 |
|---|---|
| Total debt/total capital | 0.848 |
More ▼
Growth rates in USD
Year on year, growth in dividends per share increased 5.15% while earnings per share excluding extraordinary items fell by -11.67%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 1.22% |
|---|---|
| Div growth rate (5 year) | 4.98% |
| Payout ratio (TTM) | 20.89% |
| EPS growth(5 years) | 14.30 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -11.98 |
More ▼
